BioLineRx Ltd. American Depositary Shares Share Price Today, Forecast Target, Chat & Where To Buy [BLRX]

Home > Share Prices > BioLineRx Ltd. American Depositary Shares share price (BLRX)

Today's BioLineRx Ltd. American Depositary Shares share price is 3.74 (as of 12:40 26-Sep-2025) which is a change of 0.05 or -1.32% from the last closing price of 3.74 with 16,956 shares traded giving BioLineRx Ltd. American Depositary Shares a market capitalisation of 16,039,969. The most recent daily high has been 3.86 and daily low 3.65. The BioLineRx Ltd. American Depositary Shares share price 52 week high has been 26.76 and the 52 week low 2.3. Based on the most recent BioLineRx Ltd. American Depositary Shares share price opening of 3.74, the current BioLineRx Ltd. American Depositary Shares EPS (earnings per share) are -117.56 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying BioLineRx Ltd. American Depositary Shares Shares

It currently costs 3.74 to buy one share in BioLineRx Ltd. American Depositary Shares (as of 12:40 26-Sep-2025) which is a change of 0.05 or -1.32% from the last closing price of 3.79. To buy shares in BioLineRx Ltd. American Depositary Shares you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is BioLineRx Ltd. American Depositary Shares A Good Investment?

The below BioLineRx Ltd. American Depositary Shares share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top